
Clinical Trials: More Trials, Fewer Tribulations
Clinical studies that group patients according to their molecular profile can make for better and faster drug approval decisions
Clinical studies that group patients according to their molecular profile can make for better and faster drug approval decisions
After decades of study, the evidence for whether supplements actually improve health remains polarized and incomplete
A booster vaccination may be warranted for adolescents in England to help diminish the spread of this highly contagious respiratory disease...
A congenital connective tissue disorder that confers pro basketball height also permanently benches an NBA prospect’s dreams of joining the league
The adult brain generates neurons every day. These cells help us to distinguish one memory from another—a finding that could lead to novel treatments for anxiety disorders
A lab director has reportedly been reassigned and other heads at the U.S. Center for Disease Control are likely to roll after an incident earlier this month in which at least 75 staff members may have accidentally been exposed to live samples of anthrax being transported from one lab to another...
My PhD mostly dealt with research blogs from ResearchBlogging.org (RB) an aggregator of blog posts covering peer-reviewed research. In this article, we (Prof.
New research into how and why tumors form, grow and spread is producing better screening tests and more effective remedies with fewer side effects
And a new diabetes drug targets those sweet receptors
New global clinical trial aims to replicate the mysterious “Mississippi baby” success
The use of viruses that kill bacteria as a tool for treating infections are under study again by Western researchers and governments
Alexander Shulgin, chemist and renowned psychonaut who acquainted the world with the drug MDMA - or Ecstasy - died Monday evening at his home in Lafayette, Calif.
Alexander Shulgin, the most prolific psychedelic chemist in history, has died at the age of 88. I interviewed Shulgin and his wife and co-researcher Ann at their home in California in 1999, when I was researching my 2003 book Rational Mysticism...
Compared with 50 years ago, today's heroin user is whiter, more suburban and had prescription opioids for a gateway. Dina Fine Maron reports
Drug companies have begun to share their clinical trial data. The long-overdue shift heralds a new era in medicine
Desperate to develop new drugs for malaria and other ailments, researchers are running clinical trials with traditional herbal medicines—and generating promising leads
The Resilience Project seeks to find people who are unaffected by genetic mutations that would normally cause severe and fatal disorders
Research suggests it’s a disease of the central nervous system
Biologist Gerald Edelman–one of the truly great scientific characters I’ve encountered, whose work raised profound questions about the limits of science—has died.
The placenta is full of microbes, a new study finds, raising questions about how that ecosystem and mothers' oral health influence the risk of preterm birth
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account